Mankind Pharma Q3 PAT up 9.5%, revenue rises 11.5% on chronic sales (Soban News)

Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies​Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies ​Home Page [ SOBAN NEWS: International and National ]